Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C19H25N2OS.Cl |
| Molecular Weight | 364.933 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].CC(CN1C2=CC=CC=C2SC3=CC=CC=C13)[N+](C)(C)CCO
InChI
InChIKey=FUFHLEMGRBXVCF-UHFFFAOYSA-M
InChI=1S/C19H25N2OS.ClH/c1-15(21(2,3)12-13-22)14-20-16-8-4-6-10-18(16)23-19-11-7-5-9-17(19)20;/h4-11,15,22H,12-14H2,1-3H3;1H/q+1;/p-1
| Molecular Formula | C19H24N2OS |
| Molecular Weight | 328.472 |
| Charge | 0 |
| Count |
|
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/4386346
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4386346
Promethazine hydroxyethyl quaternary derivative of promethazine with antihistamine and anticholinergic properties. The drug lacked the sedative properties of promethazine. It was used in the clinic under tradename Aprobit.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:24:36 GMT 2025
by
admin
on
Mon Mar 31 23:24:36 GMT 2025
|
| Record UNII |
O3842T8RNK
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000085088
Created by
admin on Mon Mar 31 23:24:36 GMT 2025 , Edited by admin on Mon Mar 31 23:24:36 GMT 2025
|
PRIMARY | |||
|
DTXSID70875166
Created by
admin on Mon Mar 31 23:24:36 GMT 2025 , Edited by admin on Mon Mar 31 23:24:36 GMT 2025
|
PRIMARY | |||
|
2090-54-2
Created by
admin on Mon Mar 31 23:24:36 GMT 2025 , Edited by admin on Mon Mar 31 23:24:36 GMT 2025
|
PRIMARY | |||
|
16405
Created by
admin on Mon Mar 31 23:24:36 GMT 2025 , Edited by admin on Mon Mar 31 23:24:36 GMT 2025
|
PRIMARY | |||
|
m240
Created by
admin on Mon Mar 31 23:24:36 GMT 2025 , Edited by admin on Mon Mar 31 23:24:36 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB04071MIG
Created by
admin on Mon Mar 31 23:24:36 GMT 2025 , Edited by admin on Mon Mar 31 23:24:36 GMT 2025
|
PRIMARY | |||
|
35517-04-5
Created by
admin on Mon Mar 31 23:24:36 GMT 2025 , Edited by admin on Mon Mar 31 23:24:36 GMT 2025
|
SUPERSEDED | |||
|
O3842T8RNK
Created by
admin on Mon Mar 31 23:24:36 GMT 2025 , Edited by admin on Mon Mar 31 23:24:36 GMT 2025
|
PRIMARY | |||
|
73706-86-2
Created by
admin on Mon Mar 31 23:24:36 GMT 2025 , Edited by admin on Mon Mar 31 23:24:36 GMT 2025
|
SUPERSEDED |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |